Pyridam Farma eyes IDR 400 billion through bonds’ issuance
26 Jan 2024 09:26
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company under Rejuve Global Investment, will issue its Shelf-Registration Bonds I of PYFA Phase III Year 2024, with a total principal of IDR 400 billion.